# Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE

> **NCT00180492** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 1500 (—)

## Conditions studied

- Atherosclerotic Disease, Carotid

## Interventions

- **DEVICE:** RX ACCULINK(TM) Carotid Stent System and RX ACCUNET(TM) Embolic Protection System

## Key facts

- **NCT ID:** NCT00180492
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2006-12
- **Final completion:** 2007-08
- **Target enrollment:** 1500 (—)
- **Last updated:** 2008-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180492, "Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00180492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*